Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 5 Diffuse Intrinsic Pontine Glioma 4 Recurrence 2 Glioblastoma 2 Brain Neoplasms 2 Rhabdoid Tumor 1 Oligodendroglioma 1 Neoplasms 1 Meningioma 1 Gliosarcoma 1 Astrocytoma 1

Interventions

Cyclophosphamide 14 Etoposide 12 Temozolomide 10 Carboplatin 9 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 Vincristine 7 etoposide phosphate 6 X-Rays 6 Thiotepa 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 Topotecan 5 Specimen Handling 5 Radiotherapy 5 Nuclear Medicine Department, Hospital 5 Methotrexate 5 fludarabine 4 Stem Cell Transplantation 4 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Melphalan 4 Biopsy 4 palbociclib 3 Sirolimus 3 Irinotecan 3 Ifosfamide 3 Busulfan 3 Automobiles 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdoid Tumor × Panobinostat × CNS × Clear all

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡